Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
Xtant Medical Holdings Stock

Xtant Medical Holdings Stock XTNT

XTNT
US98420P3082
A2JDJS

Price

0
Today +/-
-0
Today %
-0 %

Xtant Medical Holdings stock price

Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Xtant Medical Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Xtant Medical Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Xtant Medical Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Xtant Medical Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Xtant Medical Holdings Stock Price History

DateXtant Medical Holdings Price
8/15/20250 undefined
8/15/20250.63 undefined
8/15/20250.63 undefined
8/14/20250.63 undefined
8/13/20250.64 undefined
8/12/20250.66 undefined
8/11/20250.58 undefined
8/8/20250.64 undefined
8/7/20250.63 undefined
8/6/20250.58 undefined
8/5/20250.57 undefined
8/4/20250.58 undefined
8/1/20250.56 undefined
7/31/20250.57 undefined
7/29/20250.60 undefined
7/27/20250.63 undefined
7/25/20250.63 undefined
7/24/20250.66 undefined
7/23/20250.64 undefined
7/22/20250.65 undefined
7/21/20250.63 undefined
7/18/20250.63 undefined
7/17/20250.65 undefined

Xtant Medical Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Xtant Medical Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Xtant Medical Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Xtant Medical Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Xtant Medical Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Xtant Medical Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Xtant Medical Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Xtant Medical Holdings’s growth potential.

Xtant Medical Holdings Revenue, EBIT and net profit per share

DateXtant Medical Holdings RevenueXtant Medical Holdings EBITXtant Medical Holdings Net Income
2027e151.16 M undefined6.53 M undefined0 undefined
2026e139.28 M undefined3.88 M undefined-2.05 M undefined
2025e132.14 M undefined1.02 M undefined-4.77 M undefined
2024117.27 M undefined-12.07 M undefined-16.45 M undefined
202391.3 M undefined-10.16 M undefined660,000 undefined
202257.97 M undefined-6.76 M undefined-8.49 M undefined
202155.26 M undefined-3.85 M undefined-4.85 M undefined
202053.34 M undefined-751,000 undefined-7.02 M undefined
201964.68 M undefined-2.25 M undefined-8.22 M undefined
201872.2 M undefined-7.39 M undefined-70.1 M undefined
201782.61 M undefined-13.67 M undefined-52.41 M undefined
201690 M undefined-6.14 M undefined-19.49 M undefined
201559.35 M undefined-9.25 M undefined-2.17 M undefined
201435.33 M undefined-5.35 M undefined-10.51 M undefined
201333.07 M undefined-8.28 M undefined-12.69 M undefined
201232.98 M undefined-4.94 M undefined-7.71 M undefined
201130.15 M undefined-6.45 M undefined-3.01 M undefined
201015.42 M undefined-8.61 M undefined-19.47 M undefined
2009300,000 undefined10,000 undefined10,000 undefined
2008460,000 undefined-20,000 undefined-20,000 undefined
2007200,000 undefined10,000 undefined10,000 undefined

Xtant Medical Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
2007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
0001530323335599082726453555791117132139151
----100.006.673.136.0668.5752.54-8.89-12.20-11.11-17.193.773.6459.6528.5712.825.308.63
---80.0070.0068.7554.5562.8666.1068.8960.9859.7265.6364.1558.1856.1460.4458.1251.5248.9245.03
000122122182239625043423432325568000
000-19-3-7-12-10-2-19-52-70-8-7-4-80-16-4-20
-----84.21133.3371.43-16.67-80.00850.00173.6834.62-88.57-12.50-42.86100.00---75.00-50.00-
0.040.040.040.270.320.350.40.50.751.061.5111.7413.1628.585.4694.09126.79133.67000
---------------------
Details

Keystats

ⓘ

Revenue and Growth

The Xtant Medical Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Xtant Medical Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (k)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (k)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (k)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
200720082009201020112012201320142015201620172018201920202021202220232024
                                   
000.10.30.84.934.476.372.582.866.85.242.3418.2420.35.726.2
00.11.64.17.17.24.84.4315.3918.9912.719.9910.126.887.1510.8520.7320.66
000000000000000000
0055.48.513.110.89.5622.6826.2722.4217.316.121.4117.9517.2936.8938.63
0000.60.30.40.60.650.61.151.710.590.780.740.990.881.541.62
00.16.710.416.725.619.219.1145.0448.9939.734.6832.2531.3744.3349.3264.8767.12
003.23.43.85.25.24.6511.8215.849.917.176.86.046.477.1710.2210.96
000000000000000000
00010000000000000000
000.60.40.70.60.60.6640.2435.9413.830.570.520.460.40.3410.098.36
00000.70.70041.5341.5341.543.213.213.213.213.217.37.3
0001.51.42.43.93.532.41.80.730.790.390.40.290.20.140.1
003.85.46.68.99.78.8495.9995.1266.0111.7510.9110.110.3610.9127.7426.72
00.110.515.823.334.528.927.95141.03144.1105.7146.4243.1641.4754.6960.2392.6193.84
                                   
000000000000000000
0022.236.345.551.956.563.0981.9285.4686.25171.27179.06244.85266.07277.84294.33302.74
00-17.6-36.9-40-47.7-60.4-70.87-73.04-92.53-144.95-215.05-223.27-230.34-235.19-243.67-243.01-259.46
0000000000000-0.1-0.1-0.128.9-316.1
000000000000000000
004.6-0.65.54.2-3.9-7.778.88-7.07-58.7-43.77-44.214.5130.8834.1751.3542.96
00.11.42.83.24.43.44.1310.7911.119.486.472.192.292.623.497.057.92
000.51.43.82.43.61.929.68.9815.855.157.026.544.815.9511.258.47
000.19.72.311.61.321.050.330.130.010.0100000
002.100000010.4500000000
001.30.31.70.91.11.110.040.240.370.430.1816.823.655.774.6912.19
00.15.414.2118.79.78.4821.4731.1225.8212.059.3925.6511.0815.2222.9928.58
000.42.26.714.716.520.88110.68120.05138.5978.1476.24011.899.8717.2822.09
00000000000000002142
000006.86.6000001.731.30.840.970.970.17
000.42.26.721.523.120.88110.68120.05138.5978.1477.971.312.7310.8418.2722.29
00.15.816.417.730.232.829.36132.15151.18164.490.1987.3626.9523.8126.0641.2650.87
00.110.415.823.234.428.921.59141.03144.1105.7146.4243.1641.4754.6960.2392.6193.84
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Xtant Medical Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Xtant Medical Holdings's financial health and stability.

Assets

Xtant Medical Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Xtant Medical Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Xtant Medical Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Xtant Medical Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (k)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
20072008200920102011201220132014201520162017201820192020202120222023
000-19-3-7-12-10-2-19-52-70-8-7-4-80
00000000478632113
0000000000000000-1
000-3-5-6201-830-2-30-2-3
000162344-12740647857-7
00001103250000012
00000000000000000
000-8,000-7,000-10,000-5,000-7,000-9,000-14,00001,000000-5,000-9,000
0000-1-100-75-5-100-1-2-1-1
0000-1-100-73-5-100-1-1-1-24
000000001,0000000000-23,000
00000000000000000
00034120382132000005
0005434523000018914
0009816398416230017919
0000000000030-1000
00000000000000000
000004-111-303-1-2162-14
00.04-0.08-9.19-8.46-12.63-6.31-7.62-84.34-20.24-2.180.59-1.29-2.28-1.68-7.11-10.97
00000000000000000

Xtant Medical Holdings stock margins

The Xtant Medical Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Xtant Medical Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Xtant Medical Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Xtant Medical Holdings's sales revenue. A higher gross margin percentage indicates that the Xtant Medical Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Xtant Medical Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Xtant Medical Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Xtant Medical Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Xtant Medical Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Xtant Medical Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Xtant Medical Holdings Margin History

Xtant Medical Holdings Gross marginXtant Medical Holdings Profit marginXtant Medical Holdings EBIT marginXtant Medical Holdings Profit margin
2027e58.17 %4.32 %0 %
2026e58.17 %2.78 %-1.47 %
2025e58.17 %0.77 %-3.61 %
202458.17 %-10.3 %-14.03 %
202360.75 %-11.13 %0.72 %
202255.44 %-11.65 %-14.64 %
202158.79 %-6.97 %-8.77 %
202064.48 %-1.41 %-13.17 %
201965.73 %-3.48 %-12.71 %
201860.23 %-10.24 %-97.09 %
201760.65 %-16.54 %-63.44 %
201669.21 %-6.83 %-21.66 %
201565.86 %-15.59 %-3.66 %
201463.11 %-15.15 %-29.74 %
201357.12 %-25.04 %-38.37 %
201268.65 %-14.98 %-23.38 %
201169.78 %-21.39 %-9.98 %
201078.15 %-55.84 %-126.26 %
200926.67 %3.33 %3.33 %
200815.22 %-4.35 %-4.35 %
200735 %5 %5 %

Xtant Medical Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Xtant Medical Holdings earnings per share therefore indicates how much revenue Xtant Medical Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Xtant Medical Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Xtant Medical Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Xtant Medical Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Xtant Medical Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Xtant Medical Holdings Revenue, EBIT and net profit per share

DateXtant Medical Holdings Sales per ShareXtant Medical Holdings EBIT per shareXtant Medical Holdings Earnings per Share
2027e1.13 undefined0 undefined0 undefined
2026e1.04 undefined0 undefined-0.02 undefined
2025e0.99 undefined0 undefined-0.04 undefined
20240.88 undefined-0.09 undefined-0.12 undefined
20230.72 undefined-0.08 undefined0.01 undefined
20220.62 undefined-0.07 undefined-0.09 undefined
20210.65 undefined-0.05 undefined-0.06 undefined
20201.87 undefined-0.03 undefined-0.25 undefined
20194.91 undefined-0.17 undefined-0.62 undefined
20186.15 undefined-0.63 undefined-5.97 undefined
201754.79 undefined-9.06 undefined-34.76 undefined
201685.24 undefined-5.82 undefined-18.46 undefined
201578.65 undefined-12.26 undefined-2.88 undefined
201471.2 undefined-10.79 undefined-21.18 undefined
201382.67 undefined-20.7 undefined-31.72 undefined
201294.23 undefined-14.11 undefined-22.03 undefined
201194.22 undefined-20.16 undefined-9.41 undefined
201057.11 undefined-31.89 undefined-72.11 undefined
20097.5 undefined0.25 undefined0.25 undefined
200811.5 undefined-0.5 undefined-0.5 undefined
20075 undefined0.25 undefined0.25 undefined

Xtant Medical Holdings business model

Xtant Medical Holdings Inc. is a leading provider of medical technology and biologics, specializing in the development, manufacturing, and marketing of innovative orthopedic solutions to support patients. The company was founded in 2013 and is headquartered in Belgrade, Montana, USA. The company is focused on two main divisions: Xtant Medical and Xspine Systems. Xtant Medical specializes in the development and sale of orthopedic implants and biologics for use in spinal, sports medicine, and extremity surgery. Xtant Medical's product range includes bone replacement substitutes such as allografts, synthetic bone graft products, autologs, and matrix. Xtant Medical's products are developed and distributed by an experienced and dedicated team of physicians, engineers, and scientists who are focused on delivering innovative products of the highest quality and safety. Xspine Systems specializes in the development of innovative surgical instruments and implants for spinal surgery. Xspine Systems' product range includes implants for the lumbar spine (LWS), cervical spine (HWS), and thoracic spine (TWS), as well as surgical instruments such as kits, drills, screws, and plates. Xspine Systems' products are characterized by excellent quality and innovation, enabling surgeons to provide precise and effective treatments for their patients. Xtant Medical has a strong focus on research and development. The company has an experienced team of scientists, engineers, and surgeons who are dedicated to developing innovative solutions for the most complex medical challenges. The company has extensive research and development programs that focus on the development of high-quality implants and biologic solutions for spinal, sports medicine, and extremity surgery. The company's products are based on scientific studies that are based on evidence-based principles to ensure they meet the needs of patients and surgeons. Xtant Medical is always striving to meet the needs of its customers by providing high-quality products and services. The company has adhered to the highest quality standards and procedures to ensure that its products meet the requirements of the industry. The company works closely with surgeons and clinicians to ensure that the products meet the requirements of surgeons and the needs of patients. Xtant Medical is a leading provider of medical technology and biologics, specializing in the development, manufacturing, and marketing of innovative orthopedic solutions to support patients. The company has earned an excellent reputation for its high-quality products and services and is constantly striving to exceed the expectations of its customers. Xtant Medical Holdings is one of the most popular companies on Eulerpool.com.

Xtant Medical Holdings SWOT Analysis

Strengths

Xtant Medical Holdings Inc has several key strengths that contribute to its competitive advantage in the market:

  • Strong product portfolio: Xtant Medical offers a wide range of innovative medical devices and technologies, allowing it to cater to diverse customer needs.
  • Established brand reputation: The company has built a solid reputation for delivering high-quality, reliable products, earning the trust of both healthcare professionals and patients.
  • Strategic partnerships: Xtant Medical has partnerships with leading healthcare providers and distributors, providing access to a broad customer base and expanding market reach.
  • Experienced management team: The company is led by a skilled executive team with extensive industry knowledge and expertise, capable of making informed decisions to drive growth.

Weaknesses

Despite its strengths, Xtant Medical Holdings Inc also faces some weaknesses that need to be addressed:

  • Dependence on select products: The company's revenue heavily relies on a few key products, which makes it vulnerable to market fluctuations and competitive pressures.
  • Limited geographical presence: Xtant Medical has a relatively small market presence compared to some of its competitors, limiting its ability to reach and serve a broader customer base.
  • Pricing pressures: The highly competitive nature of the healthcare industry puts pressure on pricing, potentially affecting Xtant Medical's profitability.

Opportunities

Xtant Medical Holdings Inc can leverage the following opportunities to drive growth and market expansion:

  • Increasing demand for advanced healthcare solutions: The growing aging population and rising prevalence of chronic diseases create a favorable market environment for Xtant Medical's products.
  • Technological advancements: Continued advancements in medical technology provide opportunities for the development of new and improved products with enhanced features and benefits.
  • Emerging markets: Expanding into untapped markets, both domestically and internationally, can significantly broaden Xtant Medical's customer base and revenue streams.

Threats

Xtant Medical Holdings Inc should be aware of the following threats that may impact its business operations:

  • Intense competition: The medical devices industry is highly competitive, with numerous established players and new entrants vying for market share.
  • Regulatory challenges: Compliance with complex and evolving regulations, both in the United States and abroad, can pose challenges and increase operational costs for Xtant Medical.
  • Economic uncertainties: Economic downturns and fluctuations can adversely affect healthcare spending and demand for Xtant Medical's products.

Xtant Medical Holdings Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Xtant Medical Holdings Revenue by Segment

Segmente20232022202120202019
Orthobiologics58.61 M USD47.14 M USD42.26 M USD39.31 M USD46.66 M USD
Spinal Implant32.7 M USD10.82 M USD12.89 M USD13.88 M USD17.87 M USD
Other Revenue-11,000 USD117,000 USD149,000 USD147,000 USD

Xtant Medical Holdings Revenue by Region

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Xtant Medical Holdings Revenue by Segment

DateRest of WorldUnited States
20235.44 M USD85.86 M USD
2022807,000 USD57.16 M USD
2021693,000 USD54.57 M USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Xtant Medical Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Xtant Medical Holdings historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Xtant Medical Holdings shares outstanding

The number of shares was Xtant Medical Holdings in 2024 — This indicates how many shares 133.665 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Xtant Medical Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Xtant Medical Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Xtant Medical Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Xtant Medical Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Xtant Medical Holdings stock splits

In Xtant Medical Holdings's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Xtant Medical Holdings.

Xtant Medical Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2025-0.01 0.02  (296.08 %)2025 Q2
3/31/2025-0.01 0  (100 %)2025 Q1
12/31/2024-0.02 -0.02  (-30.72 %)2024 Q4
9/30/2024-0.03 -0.04  (-56.86 %)2024 Q3
6/30/2024-0.02 -0.03  (-47.06 %)2024 Q2
3/31/2024-0.02 -0.03  (-96.08 %)2024 Q1
12/31/2023-0.03 -0.03  (-17.65 %)2023 Q4
9/30/2023-0.02 0.07  (443.14 %)2023 Q3
6/30/2023-0.02 -0.02  (1.96 %)2023 Q2
3/31/2023-0.03 -0.02  (34.64 %)2023 Q1
1
2
3
4
...
5

Xtant Medical Holdings shareholders

%
Name
Stocks
Change
Date
54.69984 % OrbiMed Advisors, LLC73,114,592012/31/2024
8.52429 % Nantahala Capital Management, LLC11,394,000012/31/2024
5.54776 % Altium Capital Management LP7,415,413012/31/2024
5.04545 % Vizirgianakis (Stavros G)6,744,003748,6488/15/2024
1.60918 % The Vanguard Group, Inc.2,150,912012/31/2024
0.91982 % Beeson (Jonn R.)1,229,483162,1628/15/2024
0.63747 % Browne (Sean E.)852,070-105,44210/15/2024
0.59704 % Renaissance Technologies LLC798,033103,82512/31/2024
0.45689 % Bakewell (John K)610,708162,1628/15/2024
0.45559 % McNamara (Robert E)608,971162,1628/15/2024
1
2
3
4
5
...
7

Xtant Medical Holdings Executives and Management Board

Mr. Sean Browne

(58)
Xtant Medical Holdings President, Chief Executive Officer, Director (since 2019)
Compensation 1.71 M

Mr. Mark Schallenberger

(38)
Xtant Medical Holdings Chief Operating Officer
Compensation 1.17 M

Mr. Kevin Brandt

(59)
Xtant Medical Holdings Chief Commercial Officer
Compensation 947,369

Mr. Scott Neils

(40)
Xtant Medical Holdings Chief Financial Officer
Compensation 766,533

Mr. Stavros Vizirgianakis

(53)
Xtant Medical Holdings Independent Chairman of the Board
Compensation 401,464
1
2

Xtant Medical Holdings Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Premier A Stock
Premier A
SupplierCustomer-0,05-0,28-0,150,05-0,43-0,36
HCA Healthcare Stock
HCA Healthcare
SupplierCustomer-0,730,710,370,06-0,51-0,21
1

Most common questions regarding Xtant Medical Holdings

What values and corporate philosophy does Xtant Medical Holdings represent?

Xtant Medical Holdings Inc represents a commitment to improving patient lives through innovative medical solutions. With a focus on regenerative medicine products and services, Xtant Medical aims to empower surgeons and healthcare professionals to provide better outcomes for their patients. Emphasizing excellence, quality, and integrity, the company is dedicated to delivering state-of-the-art medical technologies that address complex spinal and orthopedic conditions. By leveraging cutting-edge research, clinical expertise, and advanced manufacturing capabilities, Xtant Medical strives to meet the evolving needs of patients, surgeons, and healthcare providers.

In which countries and regions is Xtant Medical Holdings primarily present?

Xtant Medical Holdings Inc is primarily present in the United States.

What significant milestones has the company Xtant Medical Holdings achieved?

Xtant Medical Holdings Inc has achieved significant milestones in its journey. The company has successfully expanded its product portfolio and established a strong presence in the medical industry. Xtant Medical Holdings Inc has consistently delivered innovative solutions and advanced technologies to provide better patient care. With its dedication to research and development, the company has introduced a range of groundbreaking products for spinal fusion and orthopedic surgeries. Xtant Medical Holdings Inc has also expanded its market reach by forming strategic partnerships and collaborations. These milestones demonstrate the company's commitment to advancing medical solutions and improving patient outcomes.

What is the history and background of the company Xtant Medical Holdings?

Xtant Medical Holdings Inc, a leading medical technology company, has a rich history and background. Founded in 2013, Xtant Medical specializes in the development, production, and commercialization of regenerative medicine products and implants that are used for orthopedic and neurological procedures. The company focuses on providing innovative solutions to enhance the healing and tissue regeneration process. Xtant Medical has an extensive product portfolio that includes bone grafts, spinal implants, and biologics. With a dedication to quality and patient outcomes, Xtant Medical has gained a strong presence in the industry, delivering advanced medical solutions to healthcare professionals and patients worldwide.

Who are the main competitors of Xtant Medical Holdings in the market?

The main competitors of Xtant Medical Holdings Inc in the market include Medtronic, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, and Globus Medical Inc.

In which industries is Xtant Medical Holdings primarily active?

Xtant Medical Holdings Inc is primarily active in the medical device and biotechnology industries.

What is the business model of Xtant Medical Holdings?

The business model of Xtant Medical Holdings Inc, a leading medical device company, focuses on developing, manufacturing, and commercializing innovative regenerative medicine products for orthopedic and neurological conditions. Xtant Medical Holdings Inc aims to enhance patient care and improve clinical outcomes through their extensive portfolio, which includes a range of biologics, implants, and instruments. By leveraging advanced technologies and strategic partnerships, Xtant Medical Holdings Inc strives to provide healthcare professionals with cutting-edge solutions to address the unmet needs of patients suffering from various musculoskeletal disorders and injuries. Please note that this answer has been optimized for SEO purposes, incorporating the company name, Xtant Medical Holdings Inc, throughout the response.

What is the P/E ratio of Xtant Medical Holdings 2025?

The P/E ratio cannot be calculated for Xtant Medical Holdings at the moment.

What is the P/S ratio of Xtant Medical Holdings 2025?

The P/S cannot be calculated for Xtant Medical Holdings currently.

What is the Quality Investing of Xtant Medical Holdings?

The Quality Investing for Xtant Medical Holdings is 6/10.

What is the revenue of Xtant Medical Holdings 2025?

The expected Xtant Medical Holdings revenue is 132.14 M USD.

How high is the profit of Xtant Medical Holdings 2025?

The expected Xtant Medical Holdings profit is -4.77 M USD.

What is the business model of Xtant Medical Holdings

Xtant Medical Holdings Inc. is a company specializing in the manufacture and distribution of orthopedic implants and biological products for the human body. The company is headquartered in Belgrade, Montana, USA and has branches in various regions, including Europe, Asia, and the Middle East. The business model of Xtant Medical is divided into two parts. Firstly, the company offers orthopedic implants such as knee, hip, and spinal supplements. Secondly, the company produces bone grafts and biological products that can promote bone growth. The company aims to produce a comprehensive range of high-quality medical implants and biological products that meet the diverse needs of patients worldwide. The implants and biological products are developed and manufactured by experienced surgeons and professionals to ensure the highest quality and safety. Xtant Medical also operates its own research and development department to continuously improve its products and develop new ones. A strong sales and marketing department is also present to acquire new customers and strengthen existing customer relationships. The company follows a multi-channel distribution strategy and works with distributors, sales partners, and direct sales teams. Some of Xtant Medical's main products include knee, hip, and spinal supplements. These implants are designed to improve the mobility and quality of life for patients. The implants are made of high-quality materials such as titanium, polyethylene, and ceramic and are available in different sizes to meet the individual needs of each patient. The company also produces a wide range of biological products that can promote bone growth. These products include bone grafts, synthetic bone substitutes, and growth factors. These products are used to repair and regenerate bones in various parts of the body. In addition to these products, Xtant Medical also offers various services, including training and education for surgeons, technical support, and customized solutions. Overall, Xtant Medical has a diversified business model that targets the needs of patients in different regions of the world. The company has a strong research and development department to continuously improve its products and operates a multi-channel distribution strategy to expand its customer base. With high-quality implants and biological products, as well as reliable customer service, Xtant Medical has established itself as one of the leading companies in the orthopedic industry.

What is the Xtant Medical Holdings dividend?

Xtant Medical Holdings pays a dividend of 0 USD distributed over payouts per year.

How often does Xtant Medical Holdings pay dividends?

The dividend cannot currently be calculated for Xtant Medical Holdings or the company does not pay out a dividend.

What is the Xtant Medical Holdings ISIN?

The ISIN of Xtant Medical Holdings is US98420P3082.

What is the Xtant Medical Holdings WKN?

The WKN of Xtant Medical Holdings is A2JDJS.

What is the Xtant Medical Holdings ticker?

The ticker of Xtant Medical Holdings is XTNT.

How much dividend does Xtant Medical Holdings pay?

Over the past 12 months, Xtant Medical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xtant Medical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Xtant Medical Holdings?

The current dividend yield of Xtant Medical Holdings is .

When does Xtant Medical Holdings pay dividends?

Xtant Medical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xtant Medical Holdings?

Xtant Medical Holdings paid dividends every year for the past 0 years.

What is the dividend of Xtant Medical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xtant Medical Holdings located?

Xtant Medical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xtant Medical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xtant Medical Holdings from 8/16/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/16/2025.

When did Xtant Medical Holdings pay the last dividend?

The last dividend was paid out on 8/16/2025.

What was the dividend of Xtant Medical Holdings in the year 2024?

In the year 2024, Xtant Medical Holdings distributed 0 USD as dividends.

In which currency does Xtant Medical Holdings pay out the dividend?

The dividends of Xtant Medical Holdings are distributed in USD.

All fundamentals about Xtant Medical Holdings

Our stock analysis for Xtant Medical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xtant Medical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.